ISBN-10:
1498704263
ISBN-13:
9781498704267
Pub. Date:
11/08/2017
Publisher:
Taylor & Francis
Nutrition and Cardiometabolic Health / Edition 1

Nutrition and Cardiometabolic Health / Edition 1

Hardcover

Current price is , Original price is $185.0. You

Temporarily Out of Stock Online

Please check back later for updated availability.

Overview

Nutrition plays a key role in prevention of cardiovascular disease, the leading cause of death worldwide. Diet influences a broad spectrum of cardiometabolic risk factors, notably a cluster including excess adiposity, dyslipidemia, impaired glucose metabolism and high blood pressure. In the face of the rapidly increasing incidence of obesity and diabetes, maintaining cardiometabolic health through adoption of a healthy lifestyle is a top public health priority.

In this book, Nutrition and Cardiometabolic Health, international experts present state-of-the-art scholarly reviews of dietary and lifestyle effects on metabolic systems associated with cardiovascular health and disease. It covers a broad range of topics including biological and behavioral processes regulating food intake; lifestyle and surgical approaches to weight loss; nutritional considerations for optimal cardiometabolic health across the lifespan; the relationship of macronutrients, whole foods and dietary patterns to diabetes and cardiovascular disease; and diet as a modulator of gene expression, epigenetics and the gut microbiome and the relationship of these traits to disorders of metabolism. This book provides its readers with an authoritative view of the present state of knowledge of dietary effects on cardiometabolic health and will be of interest to nutrition and healthcare professionals alike.

Product Details

ISBN-13: 9781498704267
Publisher: Taylor & Francis
Publication date: 11/08/2017
Pages: 642
Product dimensions: 7.00(w) x 10.00(h) x (d)

About the Author

Nathalie Bergeron is Professor of Biological Sciences at Touro University California College of Pharmacy, and associate staff scientist in the Atherosclerosis Research Program at Children’s Hospital Oakland Research Institute. She was trained in dietetics and nutritional biochemistry and graduated from Laval University, Canada, with a PhD in nutrition. She pursued her postdoctoral training at the Cardiovascular Research Institute of the University of California, San Francisco, where she specialized in postprandial lipoprotein metabolism. Dr. Bergeron began her academic career as a Research Professor at Laval University in 1996. She was a visiting professor at the Department of Nutritional Sciences and Toxicology at the University of California, Berkeley, from 2000-2002 and joined Touro University, California College of Pharmacy, at its inception in 2005. At Touro Dr. Bergeron teaches in the areas of pathophysiology of metabolic diseases, as well as nutrition. Dr. Bergeron also holds a Staff Scientist position at Children’s Hospital Oakland Research Institute (CHORI). Dr. Bergeron’s research is clinical in nature and focuses on dietary composition, with a special emphasis on carbohydrate quantity and quality, and its relationship to features of atherogenic dyslipidemia. Her more recent research activities include looking at variations of the DASH and Mediterranean dietary patterns and their relationship to cardiometabolic health. Over the course of her academic career, she has received research grants from the Medical Research Council of Canada, the Heart and Stroke Foundation of Canada, the American Diabetes Association and the National Institutes of Health, along with investigator-initiated funding from the Dairy Farmers of Canada, the Dairy Research Institute and the Almond Board of California.

Patty W. Siri-Tarino is Associate Staff Scientist in the Atherosclerosis Research Program and Program Director of the Family Heart & Nutrition Center at Children’s Hospital Oakland Research Institute. She obtained her undergraduate degree in Biology at Tufts University, Master’s of Science in Epidemiology at the Netherlands Institute of Health Sciences and PhD in Nutrition and Metabolic Biology at Columbia University where she developed a transgenic mouse model of insulin resistance, obesity and dyslipidemia. Dr. Siri-Tarino began her post-doctoral work by developing and conducting studies in humans aimed at understanding variability in the postprandial response to high-fat meals and the role of cholesterol absorption inhibitors in its modulation. She subsequently worked on dietary intervention studies evaluating macronutrient effects on CVD risk profiles in the context of weight loss and stability as well as studies evaluating genetic effects on energy metabolism at rest and during exercise. Dr. Siri-Tarino has spoken nationally and internationally on the role of diet on lipoprotein profiles as biomarkers of cardiovascular disease and published peer-reviewed journal articles, reviews, book chapters and popular media articles on diet, lifestyle and genetic determinants of heart health. She is interested in community engagement and education.

George A. Bray, M.D., MACP, MACE is a Boyd Professor Emeritus at the Pennington Biomedical Research Center of Louisiana State University in Baton Rouge, Louisiana, and Professor of Medicine Emeritus at the Louisiana State University Medical Center in New Orleans. After graduating from Brown University summa cum laude in 1953, Bray entered Harvard Medical School graduating magna cum laude in 1957. His post-doctoral training included an internship at The Johns Hopkins Hospital, Baltimore, MD, a fellowship at the NIH, residence at the University of Rochester, a fellowship at the National Institute for Medical Research in London and at the Tufts-New England Medical Center in Boston. In 1970, he became Director of the Clinical Research Center at the Harbor UCLA Medical Center, and the organizer of the First Fogarty International Center Conference on Obesity in 1973. Bray Chaired the Second International Congress on Obesity in Washington DC in 1977. In 1989 he became the first Executive Director of the Pennington Biomedical Research Center in Baton Rouge, a post he held until 1999. He is a Master of the American College of Physicians, Master of the American College of Endocrinology and Master of the American Board of Obesity Medicine. Bray founded the North American Association for the Study of Obesity in 1982 (now The Obesity Society), and he was the founding editor of its journal, Obesity Research, as well as co-founder of the International Journal of Obesity and the first editor of Endocrine Practice, the official journal of the American College of Endocrinologists. Dr. Bray has received many awards during his medical career including the Johns Hopkins Society of Scholars, Honorary Fellow of the American Dietetic Association, the Bristol-Myers Squibb Mead-Johnson Award in Nutrition, the Joseph Goldberger Award from the American Medical Association, the McCollum Award from the American Society of Clinical Nutrition, the Osborne-Mendel Award from the American Society of Nutrition, the TOPS Award, the Weight Watchers Award, the Stunkard Lifetime Achievement Award, and the Presidential Medal from The Obesity Society . During his 50 academic years Bray authored or coauthored more than 1,900 publications, ranging from peer-reviewed articles and reviews, to books, book chapters and abstracts reflected in his Hirsch (H) Index of 89. Bray has had a long interest in the history of medicine and has written articles and a book on the history of obesity.

Ronald M. Krauss, M.D., is Senior Scientist and Dorothy Jordan Endowed Chair at Children’s Hospital Oakland Research Institute, Professor of Medicine at UCSF, and Adjunct Professor of Nutritional Sciences at UC Berkeley. He received his undergraduate and medical degrees from Harvard University with honors and served his internship and residency on the Harvard Medical Service of Boston City Hospital. He then joined the staff of the National Heart, Lung, and Blood Institute in Bethesda, Maryland, first as Clinical Associate and then as Senior Investigator in the Molecular Disease Branch. Dr. Krauss is board-certified in internal medicine, endocrinology and metabolism, and is a member of the American Society for Clinical Investigation, a Fellow of the American Society of Nutrition and the American Heart Association (AHA), and a Distinguished Fellow of the International Atherosclerosis Society. He has served on the U.S. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, was the founding chair of the AHA Council on Nutrition, Physical Activity, and Metabolism, and is a National Spokesperson for the AHA. Dr. Krauss has also served on both the Committee on Dietary Recommended Intakes for Macronutrients and the Committee on Biomarkers of Chronic Disease of the Institute of Medicine of the National Academy of Sciences. He has received numerous awards including the AHA Scientific Councils Distinguished Achievement Award, the Centrum Center For Nutrition Science Award of the American Society for Nutrition, the Distinguished Leader in Insulin Resistance from the International Committee for Insulin Resistance, and the AHA Award of Meritorious Achievement. In addition he has been been the Robert I. Levy Lecturer of the AHA, the Edwin Bierman Lecturer for the American Diabetes Association, and the Margaret Albrink Lecturer at West Virginia University School of Medicine. Dr. Krauss is on the editorial boards of a number of journals, and has been Associate Editor of Obesity, the Journal of Lipid Research, and the Journal of Clinical Lipidology. He has published nearly 500 research articles and reviews on genetic, dietary, and drug effects on plasma lipoproteins and coronary artery disease. Among his accomplishments is the identification of atherogenic dyslipidemia, a prevalent lipoprotein trait (high triglyceride, low HDL, and increase in small, dense LDL particles) that is associated with risk of cardiovascular disease and type 2 diabetes. In recent years Dr. Krauss’ work has focused on interactions of genes with dietary and drug treatments that affect metabolic phenotypes and cardiovascular disease risk.

Table of Contents

Contents

Preface

Editors

Contributors

Section I _Energy Balance, Adiposity, and

Cardiometabolic Health

Chapter 1 Regulation of Food Intake: The Gut–Brain Axis

Surya Panicker Rajeev, Ian W. Seetho, and John P. H. Wilding

Chapter 2 Overeating Behavior and Cardiometabolic Health: Mechanisms and Treatments

Ashley E. Mason and Frederick M. Hecht

Chapter 3 Energy Balance and Regulation of Body Weight: Are All Calories Equal?

Kevin D. Hall

Chapter 4 Diets for Weight Loss

George A. Bray and Patty W. Siri-Tarino

Chapter 5 Weight Loss by Surgical Intervention: Nutritional Considerations and Influence

on Health

Karim Kheniser and Sangeeta Kashyap

Chapter 6 Physical Activity and Cardiometabolic Health

Andrea M. Brennan and Robert Ross

Chapter 7 Diet as a Potential Modulator of Body Fat Distribution

Sofia Laforest, Geneviève B. Marchand, and AndrŽ Tchernof

Chapter 8 Nutritional Considerations for Cardiometabolic Health in Childhood and

Adolescent Obesity

Elizabeth Prout Parks, Jennifer Panganiban, Stephen R. Daniels,

and Julie Brothers

Chapter 9 Aging and Cardiovascular Disease: Lessons from Calorie Restriction

Jasper Most and Leanne M. Redman

Section II Dietary Fats and Cardiometabolic Health

Chapter 10 Omega-3 and Omega-6 Fatty Acids: Roles in Cardiometabolic Disease

William S. Harris

Chapter 11 Evolving Role of Saturated Fatty Acids

Patty W. Siri-Tarino and Ronald M. Krauss

Chapter 12 Effects of Dietary Trans Fatty Acids on Cardiovascular Risk

Ronald P. Mensink

Section III _Dietary Carbohydrates and

Cardiometabolic Health

Chapter 13 Epidemiologic and Mechanistic Studies of Sucrose and Fructose in Beverages

and Their Relation to Obesity and Cardiovascular Risk

George A. Bray

Chapter 14 Effects and Mechanisms of Fructose-Containing Sugars in the Pathophysiology

of Metabolic Syndrome

Kimber L. Stanhope and Peter J. Havel

Chapter 15 Dietary Carbohydrate Restriction in the Management of NAFLD and

Metabolic Syndrome

Grace Marie Jones, Kathleen Mulligan, and Jean-Marc Schwarz

Chapter 16 Dietary Starches and Grains: Effects on Cardiometabolic Risk

Nathalie Bergeron and Ronald M. Krauss

Section IV Dietary Protein and Cardiometabolic Health

Chapter 17 Interaction of Dietary Protein and Energy Balance

Eveline A. Martens, Richard D. Mattes, and Margriet S. Westerterp-Plantenga

Chapter 18 A Protein-Centric Perspective for Skeletal Muscle Metabolism and

Cardiometabolic Health

Donald K. Layman

Chapter 19 Protein Sources, CVD, Type 2 Diabetes, and Total MortalityPeter Clifton

Chapter 20 Consumption of Foods, Food Groups, and Cardiometabolic Risk

Edward Yu and Frank B. Hu

Chapter 21 Dietary Patterns and Cardiometabolic Disease

Elizabeth M. Cespedes Feliciano and Frank B. Hu

Chapter 22 The Mediterranean Diet to Prevent Type 2 Diabetes and Cardiovascular Disease

Michel de Lorgeril

Chapter 23 The DASH Diet

Catherine M. Champagne

Chapter 24 Nut Consumption and Coronary Heart Disease (CHD) Risk and Mortality

Christina Link, Alyssa Tindall, Jordi Salas-Salvadó, Caitlin Lynch, and

Penny Kris-Etherton

Chapter 25 Dairy Product Consumption, Dairy Fat, and Cardiometabolic Health

Benoît Lamarche

Chapter 26 Paleolithic Diets

Staffan Lindeberg, Maelán Fontes Villalba, Pedro Carrera-Bastos, and

Lynda Frassetto

Chapter 27 Fasting Intermittently or Altering Meal Frequency: Effects on Plasma Lipids

John F. Trepanowski and Krista A. Varady

Section VI Other Nutritional Influences

of Cardiometabolic Health

Chapter 28 Early-Life Nutrition, Epigenetics, and Later Cardiometabolic Health

Mark H. Vickers, Clare M. Reynolds, and Clint Gray

Chapter 29 Gene–Diet Interactions

Silvia Berciano and Jose M. Ordovas

Chapter 30 Gut Microbiome: Its Relationship to Health and Its Modulation by Diet

Brian J. Bennett and Katie A. Meyer

Chapter 30 Gut Microbiome: Its Relationship to Health and Its Modulation by Diet

Brian J. Bennett and Katie A. Meyer

Chapter 31 Alcohol: Associations with Blood Lipids, Insulin Sensitivity, Diabetes,

Clotting, CVD, and Total Mortality

Charlotte Holst and Janne Schurmann Tolstrup

Chapter 32 Endocrine Disrupting Chemicals, Obesogens, and the Obesity Epidemic

Raquel Chamorro-Garcia and Bruce Blumberg

Index

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews